Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck KGaA Follows Pfizer With Archemix Deal For Aptamer-Based Therapeutics

Related Content

Merck KGaA Builds On Diabetes Portfolio With DPP-IV Inhibitor

Oct 18 2006

Pfizer Invests In Potential New Drug Class

Jan 09 2007

Merck KGaA Strengthens Its Biotech Presence With Serono Acquisition

Sep 25 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window